| Dr Jennifer Ann Mock, MD | |
|
6488 Weddington-monroe Road, Wesley Chapel, NC 28104 | |
| (704) 384-1020 | |
| (704) 384-1021 |
| Full Name | Dr Jennifer Ann Mock |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 6488 Weddington-monroe Road, Wesley Chapel, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639252026 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2010-00243 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Medical Group Inc | 1153234893 | 1996 |
News Archive
A new study that challenges the prevailing view of how bowel cancer develops in the large intestine is published today in Nature Medicine.
According to the Centers for Disease Control, approximately four out of five black women are overweight or obese and 36 percent meet physical activity objectives as determined by the CDC.
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Today, as AstraZeneca reports 2 billion doses of the COVID-19 vaccine released for supply University of Oxford scientists explain how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented strategy used to improve international equity of access.
› Verified 9 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
A new study that challenges the prevailing view of how bowel cancer develops in the large intestine is published today in Nature Medicine.
According to the Centers for Disease Control, approximately four out of five black women are overweight or obese and 36 percent meet physical activity objectives as determined by the CDC.
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Today, as AstraZeneca reports 2 billion doses of the COVID-19 vaccine released for supply University of Oxford scientists explain how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented strategy used to improve international equity of access.
› Verified 9 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306950282 PECOS PAC ID: 1153234893 Enrollment ID: O20040204001028 |
News Archive
A new study that challenges the prevailing view of how bowel cancer develops in the large intestine is published today in Nature Medicine.
According to the Centers for Disease Control, approximately four out of five black women are overweight or obese and 36 percent meet physical activity objectives as determined by the CDC.
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Today, as AstraZeneca reports 2 billion doses of the COVID-19 vaccine released for supply University of Oxford scientists explain how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented strategy used to improve international equity of access.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Ann Mock, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: (704) 316-2021 | Dr Jennifer Ann Mock, MD 6488 Weddington-monroe Road, Wesley Chapel, NC 28104 Ph: (704) 384-1020 |
News Archive
A new study that challenges the prevailing view of how bowel cancer develops in the large intestine is published today in Nature Medicine.
According to the Centers for Disease Control, approximately four out of five black women are overweight or obese and 36 percent meet physical activity objectives as determined by the CDC.
New research led by Hana El-Samad of the University of California, San Francisco, and the Chan-Zuckerberg Biohub confirmed the beneficial use of an antiviral therapeutic called SARSNotch, which uses a combination of the SynNotch platform and de-novo designed protein binders. SARSNotch uses sentinel T cells to detect and mount a genetic response toward the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Today, as AstraZeneca reports 2 billion doses of the COVID-19 vaccine released for supply University of Oxford scientists explain how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented strategy used to improve international equity of access.
› Verified 9 days ago